In alignment with our commitment to scientific innovation and areas of unmet medical need, we may provide product and funding support for independent research in rare diseases and genetic disorders.
This program supports the following types of Investigator Initiated Studies:
- Clinical studies of approved and investigational uses of BioMarin medicines, including medicines approved by the FDA or still in development (i.e. interventional studies phase I to IV).
- Clinical observational studies, real world evidence (i.e. non-interventional studies)
- Clinical studies requesting BioMarin product only
This program does not provide support for animal model studies, CME or non-CME educational activities, event sponsorships, or charitable contributions.
Our medical science staff located throughout the globe are available to guide you through each step in the application process. If you have a concept you would like to submit, please reach out to your Medical Science Liaison (MSL) or Area Medical Director. If you don’t yet have a medical staff contact or for general inquiries, please email us at: firstname.lastname@example.orgLogin and apply for support or review submitted applications ⌃